Long-term efficacy and safety of ramosetron in the treatment of diarrhea-predominant irritable bowel syndrome.
about
Irritable bowel syndrome: new insights into symptom mechanisms and advances in treatmentRamosetron in irritable bowel syndrome with diarrhea: new hope or the same old story?Irritable bowel syndrome: a disease still searching for pathogenesis, diagnosis and therapyRecent advances in pharmacological treatment of irritable bowel syndrome.Irritable Bowel Syndrome: Peripheral Mechanisms and Therapeutic ImplicationsEfficacy and safety of 5-hydroxytryptamine 3 receptor antagonists in irritable bowel syndrome: A systematic review and meta-analysis of randomized controlled trialsCurrent and emergent pharmacologic treatments for irritable bowel syndrome with diarrhea: evidence-based treatment in practice.Treatment of abdominal pain in irritable bowel syndrome.New and Investigational Agents for Irritable Bowel Syndrome.Eluxadoline for the treatment of diarrhoea-predominant irritable bowel syndrome.Regulating effect of TongXie-YaoFang on colonic epithelial secretion via Cl- and HCO3- channel.Effect of ramosetron in female patients with irritable bowel syndrome with diarrhea: a phase III long-term study.
P2860
Q26751193-E1DDC727-0665-44B1-9212-8BB61310DF14Q33656496-E22563A1-0457-4215-87C3-655D05BD5B31Q33958808-B8475D0B-3C1F-4150-B483-D2EEE8533FC5Q33958853-F732ECF0-B415-4CC5-ACE5-DC3B5CD644BBQ36207200-E3C4952F-A90A-411E-8933-916E55730CFCQ36307366-CBEDEAA9-03D2-4F4F-8BA5-CB40EFDD32E6Q37632259-F7DF10ED-027C-4025-B3AE-173432166F33Q38213185-88101FCB-29AF-4BFF-8BA8-34D065C0FD8AQ38601834-7B0DE3A4-C9AC-4734-A88A-EF2DB9C13DC7Q38856699-E767ED67-EEB0-4132-AB92-D50FC9E3402CQ40038311-251DFC2E-1BE0-4F68-ADDE-7BA1195A6909Q40072180-F234251D-542F-48D4-8EF8-5FB0B29930A9
P2860
Long-term efficacy and safety of ramosetron in the treatment of diarrhea-predominant irritable bowel syndrome.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Long-term efficacy and safety ...... nant irritable bowel syndrome.
@en
Long-term efficacy and safety ...... nant irritable bowel syndrome.
@nl
type
label
Long-term efficacy and safety ...... nant irritable bowel syndrome.
@en
Long-term efficacy and safety ...... nant irritable bowel syndrome.
@nl
prefLabel
Long-term efficacy and safety ...... nant irritable bowel syndrome.
@en
Long-term efficacy and safety ...... nant irritable bowel syndrome.
@nl
P2093
P2860
P356
P1476
Long-term efficacy and safety ...... nant irritable bowel syndrome.
@en
P2093
Kazunari Yamamoto
Kazuyuki Suzuki
Shoko Sato
Toshimi Chiba
P2860
P304
P356
10.2147/CEG.S32721
P407
P577
2013-07-25T00:00:00Z